Skip to content

Clinical trials

Phase 2 Urinary Bladder Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 2 Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20183
20203
20215
20223
20234
20241
20252
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Unknown status8
Completed5
Not yet recruiting4
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University2
RenJi Hospital2
Sun Yat-sen University2
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2
Tianjin Medical University Second Hospital2
Bayer1
Beijing Huanxing Cancer Hospital1
Bristol-Myers Squibb1
Changhai Hospital1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms30
Carcinoma, Transitional Cell5
Non-Muscle Invasive Bladder Neoplasms4
Endometrial Neoplasms3
Breast Neoplasms2
Esophageal Neoplasms2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Uterine Cervical Neoplasms2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.